3/3/2021 5:06:23 PM
Bio-Techne To Acquire Asuragen
2/23/2021 7:14:41 AM
Bio-Techne, Luminary Agree For Use Of Bio-Techne's TcBuster For Development Of Luminary's CAR-T Cell Therapies
2/2/2021 6:41:12 AM
Bio-Techne Declares Q2 Dividend Of $0.32/Shr; Record Feb 12/payable Feb 26
2/2/2021 6:32:05 AM
Bio-Techne Q2 GAAP EPS $1.15; Adj EPS $1.62
1/28/2021 7:06:52 AM
Bio-Techne Unveils Initial Minority Strategic Equity Stake In Changzhou Eminence Biotechnology Co.
12/2/2020 7:11:07 AM
Regulus Therapeutics, Bio-Techne Collaborate For Biomarker Development
11/25/2020 7:35:54 AM
Kantaro Receives FDA Emergency Use Authorization For COVID-SeroKlir
11/5/2020 6:33:29 AM
Bio-Techne Declares Dividend Of $0.32, Payable Nov. 27, Record Nov. 16
11/5/2020 6:32:12 AM
Bio-Techne Q1 GAAP EPS $0.83 Vs $0.37 Year Ago
10/26/2020 7:47:06 AM
Kantaro Gets CE Marking For COVID-SeroKlir And COVID-SeroIndex, Kantaro's Quantitative SARS-CoV-2 IgG Antibody Test Kits
10/19/2020 7:03:39 AM
Bio-Techne Announces Commercial Release Of SARS-CoV-2 Multi-Antigen Serology Assay Kit For Simple Western
10/1/2020 7:06:32 AM
Bio-Techne Announces Opening Of Its New Canadian Office In Toronto